Intellia Therapeutics Long Term Deferred Assets (Quarterly) Trends

Intellia Therapeutics, Inc. (NTLA)

12.50 +0.63 (+5.31%) USD | NASDAQ | Jan 16, 16:00

12.50 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for NTLA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Beam Therapeutics, Inc.	--
ANI Pharmaceuticals, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Pacific Biosciences of California, Inc.	--
Twist Bioscience Corp.	--